GroundRules
24-A M.R.S. §4320-W: Coverage for blood testing for PFAS
Where this section sits in the code
- TITLE 24-A: MAINE INSURANCE CODE
- CHAPTER 56-A: HEALTH PLAN IMPROVEMENT ACT
- SUBCHAPTER 1: HEALTH PLAN REQUIREMENTS
1. Definition. As used in this section, unless the context otherwise indicates, "perfluoroalkyl and polyfluoroalkyl substances" or "PFAS" means any member of the class of fluorinated organic chemicals containing at least one fully fluorinated carbon atom.
2. Required coverage. A carrier offering a health plan in this State shall provide coverage for blood testing for perfluoroalkyl and polyfluoroalkyl substances that is recommended by a provider as medically necessary health care for an enrollee. For the purposes of this subsection, blood testing for PFAS is presumed to be medically necessary health care for an enrollee if a provider determines that the enrollee meets clinical guidelines for blood testing for PFAS established by the National Academies of Sciences, Engineering, and Medicine, its successor organization or a comparable organization.
Collected 2026-10-10T12:16:22Z. Source file · JSON
All copyrights and other rights to statutory text are reserved by the State of Maine. The text included in this publication reflects changes made through the First Special Session of the 132nd Maine Legislature and is current through January 1, 2026. The text is subject to change without notice. It is a version that has not been officially certified by the Secretary of State. Refer to the Maine Revised Statutes Annotated and supplements for certified text. The Office of the Revisor of Statutes also requests that you send us one copy of any statutory publication you may produce. Source